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Axial myopathy can be the underlying cause of rapidly progressive adult-onset scoliosis; however, the pathogenesis
of this disorder remains poorly understood. Here we present a case of a 69-year old woman with a family history of
scoliosis affecting both her mother and her son, who over 4 years developed rapidly progressive scoliosis. The
patient had a history of stable scoliosis since adolescence that worsened significantly at age 65, leading to low back
pain and radiculopathy. Paraspinal muscle biopsy showed morphologic evidence of a mitochondrial myopathy.
Diagnostic deficiencies of electron transport chain enzymes were not detected using standard bioassays, but
mitochondrial immunofluorescence demonstrated many muscle fibers totally or partially deficient for complexes I,
III, IV-I, and IV-IV. Massively parallel sequencing of paraspinal muscle mtDNA detected multiple deletions as well as a
40.9% heteroplasmic novel m.12293G > A (MT-TL2) variant, which changes a G:C pairing to an A:C mispairing in the
anticodon stem of tRNA LeuCUN. Interestingly, these mitochondrial abnormalities were not detected in the blood of
either the patient or her son, suggesting that the patient’s rapidly progressive late onset scoliosis was due to the
acquired paraspinal mitochondrial myopathy; the cause of non-progressive scoliosis in the other two family
members currently remains unexplained. Notably, this case illustrates that isolated mitochondrial myopathy can
underlie rapidly-progressive adult-onset scoliosis and should be considered in the differential diagnosis of the
primary axial myopathy.
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While adult scoliosis is a common disorder of the spine
that often follows adolescent deformity, rapid progression
of scoliosis with decompensation of posture occurs only
rarely in the adult. Rapidly progressive adult-onset scoli-
osis is a debilitating and frequently painful condition that
is poorly understood and typically considered idiopathic.
One particularly well-known manifestation of adult-onset
scoliosis is camptocormia or “bent-spine syndrome,” in
which the patient’s spine is involuntarily flexed when
standing or sitting [1]. Until recently, little was known
about the heritable and acquired factors leading to camp-
tocormia, aside from an unclear but reproducible relation-
ship to Parkinson’s disease [2–4]. However, recent work
has demonstrated that camptocormia can be due to a lo-
calized axial myopathy leading to spinal instability [5].* Correspondence: Marta.Margeta@ucsf.edu
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unless otherwise stated.While axial myopathies can be secondary to other neuro-
muscular disorders, in some cases they appear to arise de
novo and are designated primary axial myopathies. While
etiologically heterogeneous, this group of conditions is clin-
ically characterized by progressive paraspinal muscle weak-
ness, myogenic pattern on EMG, and normal to mildly
elevated creatinine kinase (CK) levels. Pathologically, af-
fected paraspinal muscles typically show chronic myopathic
changes reminiscent of muscular dystrophy (fiber size vari-
ation, fatty infiltration, and fibrosis [5]). Interestingly, mito-
chondrial changes (ragged red and cytochrome c oxidase
(COX)-negative fibers) have also been observed in primary
axial myopathies [6,7], but are generally thought to repre-
sent non-specific age-related mitochondrial pathology.
However, a recent illustrative report demonstrated that her-
itable mitochondrial DNA (mtDNA) mutations can also
cause an axial myopathy [8]: a familial late-onset axial my-
opathy due to mutation in the mitochondrial tRNA Phe
gene was demonstrated in two elderly sisters with a history
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ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Hiniker et al. Acta Neuropathologica Communications 2014, 2:137 Page 2 of 9
http://www.actaneurocomms.org/content/2/1/137Here, we report a case of rapidly progressive adult-
onset scoliosis due to late-onset axial myopathy associ-
ated with multiple somatic mtDNA abnormalities but
without chronic myopathic features typically observed in
primary axial myopathies. This case demonstrates that
adult spinal deformity may be secondary to a previously
undiagnosed neuromuscular pathology and that primary
axial myopathy can be due to an apparently isolated
mitochondrial myopathy.
Materials and methods
Biopsy of T8 paraspinal muscle was obtained intraopera-
tively during stage one of the two-stage spinal fusion. The
flash-frozen muscle tissue was evaluated using a standard
panel of muscle stains (hematoxylin and eosin [H&E];
modified trichrome; ATPase, pH= 9.4; NADH reductase;
SDH; and COX). Light microscopy images were acquired
with a DP72 digital camera on a BX41 bright-field light
microscope using cellSens Entry 1.4 software (all by
Olympus Corp.). For electron microscopy, ultrathin (80 nm)
sections of the glutaraldehyde-fixed, Epon-embedded tissue
were stained with 2% uranyl acetate. Sections were exam-
ined in a Tecnai G212 transmission electron microscope at
80 kV, with images obtained with a Hammamatsu camera
model Orca HR.
Standard biochemical assays for enzyme activities of the
electron transport chain were performed in duplicate on
fresh frozen tissue at 30°C, according to previously pub-
lished methods [9,10]. The activities of complex I (NADH:
ferricyanide dehydrogenase), complex II (succinate de-
hydrogenase), complex I + III (NADH: cytochrome C oxi-
dase), complex II + III (succinate:cytochrome c reductase),
and complex IV (cytochrome c oxidase) were measured
using different electron acceptors/donors. Complex I was
followed using the oxidation of NADH at 340 nm. Com-
plex II activity was measured via the reduction of 2,6-
dichloroindophenol (DCIP) at 600 nm. Citrate synthase
was used as a marker for overall mitochondrial content.
Immunofluorescence staining with antibodies specific
for subunits of five respiratory chain complexes was
performed at the Molecular Neuropathology Laboratory,
Texas Children’s Hospital. All antibodies were obtained
from Abcam [Complex I, anti-NDUFS3 (ab110246); Com-
plex II, anti-SDHB (ab14714); Complex III, anti-UQCRC2
(ab14745); Complex IV-I, anti-MTCO-1 (ab14705); Com-
plex IV-IV, anti-COX IV (ab14744); Complex V, anti-
OSCP (ab110276); PDH, anti-Pyruvate dehydrogenase E1
component subunit alpha (ab 110334)]. Cryosections of
skeletal muscle were processed for immunofluorescence
using a previously described protocol [11] with the above
antibodies to respiratory chain enzyme complex proteins
(green fluorescence); antibody to porin (Abcam ab14734;
red fluorescence) served as reference control for mito-
chondrial density and distribution. Images were capturedusing Leica imaging system with Cytovision software. For
each complex, fibers with strong red (porin) staining but
no green staining were considered totally deficient (i.e.
homoplasmic for mutant mitochondria), fibers with a
patchy green and red staining were considered partially de-
ficient (i.e. heteroplasmic for mutant mitochondria), while
fibers lacking both red and green staining were considered
mitochondrially hypodense.
Comprehensive mtDNA analysis by massively parallel
(“next generation”) sequencing was performed on the
paraspinal muscle and blood according to previously pub-
lished methods [12,13]. Briefly, the entire mitochondrial
genome was amplified using long-range PCR. The PCR
products were sequenced to approximately 20,000 depth
of coverage using the Illumina Hiseq. 2000, with the Re-
vised Cambridge Reference Sequence (rCRS NC_012920)
used as reference. The quantitative measurements of refer-
ence base and observed base for a single variant were re-
ported as mean percentage value, with coding region
variants reported for heteroplasmy ≥1.5%. Sanger sequen-
cing was performed for sequence confirmation of het-
eroplasmic findings in the coding region that exceeded
20% heteroplasmy. Massively parallel sequencing of
mtDNA followed by Sanger sequencing of the breakpoint
(deletion/junction) regions was used for mtDNA deletion
analysis, as described previously [12,13]. mtDNA copy
number was determined according to published proce-
dures [14]. Finally, nuclear genome regions that include 14
nuclear genes (C10ORF2, DGUOK, MPV17, OPA1,
OPA3, POLG, POLG2, RRM2B, SLC25A4, SUCLG1,
SUCLG2, TK2, and TYMP) known to be involved in the
maintenance of mtDNA integrity and the deoxynucleotide




At age 65, the female patient developed progressive scoli-
osis consisting of decompensated deformity with severe
sagittal and coronal plane imbalance that worsened rapidly
over the next four years; past medical history was signifi-
cant for stable scoliosis identified in the late adolescence.
The patient also had a history of borderline hypertension
and hyperlipidemia with transient ischemic attack (TIA)
at age 62; rhytidectomy at age 64; and elbow surgery at
age 66. Family history was positive for stable scoliosis in
both her mother (who died at age 95) and her son (cur-
rently age 37). The patient reported increasing lumbosa-
cral and leg pain as the scoliosis progressed; in addition,
she developed mild dysphagia in the year preceding sur-
gery, but has not undergone any additional testing to
evaluate this symptom. She has normal stature (164 cm)
and has reported no headaches, no myoclonus, no diplo-
pia, no hearing loss, and no exercise intolerance.
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formity with severe sagittal and coronal plane imbalance.
There was no evidence of muscle wasting. Neurologic
exam showed no evidence of ocular movement abnormal-
ities, but mild left deltoid (4+/5) and neck flexion (4/5)
weakness was present. X-ray imaging showed right-sided
major thoracolumbar curve, with a progressive curvature
from T10 to L4 (71 degrees with significant rotational
element), along with flexional curvature at L4-5 to L5-S1
level. Magnetic Resonance Imaging (MRI) showed severe
right curvature of the thoracolumbar spine (Figure 1a)
with bilateral fatty atrophy of the posterior paraspinal
musculature (Figure 1b; a somewhat nonspecific finding
in the patent’s age group). There were no areas of severe
stenosis and no evidence of intraspinal abnormalities. The
patient had a normal CK level; electromyography of
paraspinal muscles was not performed. At age 69, due
to continued pain and deformity, the patient underwent
a two-stage spinal fusion with paraspinal muscle biopsy.
20 months after completing both stages of surgery, theFigure 1 Paraspinal muscle imaging. Fatty replacement of the
patient’s paraspinal musculature is demonstrated on coronal
T1-weighted MRI image (a), which also shows severe scoliosis, and
on axial T2-weighted MRI image at spinal level L4 (b).patient shows no evidence of recurrent deformity and
has not developed additional neuromuscular symptoms.
Muscle pathology and molecular genetics
Light microscopic examination of the paraspinal muscle
biopsy showed evidence of a mitochondrial myopathy,
with frequent well-developed ragged red fibers demon-
strated on trichrome stain and subsarcolemmal crescents
(mitochondrial aggregates) on NADH and SDH stains; a
significant proportion (approximately 6%) of muscle fi-
bers was COX-negative (Figures 2a-c). [While relatively
little is known about the baseline staining parameters of
infrequently biopsied paraspinal muscles, mitochondrial
abnormalities are uncommon: a search of the UCSF
archival material uncovered four paraspinal muscle biop-
sies from the patients in the same age range (58–71
years) that showed a spectrum of myopathic and neuro-
genic changes but only rare ragged red fibers (maximally
1–2 per biopsy) and no COX-negative fibers.] H&E stain
of the patient’s biopsy showed scattered degenerating/re-
generating fibers and mild fiber size variation without
evidence of inflammation or fibrosis. Ultrastructural
analysis demonstrated mitochondrial hyperplasia and
hypertrophy with frequent abnormal mitochondria and
abundant mitochondrial inclusions (abundant matrical
dense granules and well developed crystalline arrays;
Figures 2d-f ). Additionally, there was an increase in the
number and size of lipid droplets and a mild increase in
the amount of glycogen. Focal findings included disrup-
tion of the myofibrillary matrix, Z-band streaming, and
a single focus of nemaline rods.
Significant deficiencies of electron transport chain
enzymes were not detected using standard biochemical
assays (Table 1). Despite the absence of detectable bio-
chemical abnormalities, immunofluorescence staining
with antibodies specific for subunits of the five respira-
tory chain complexes showed many muscle fibers with
reduced expression or total absence of individual com-
plexes (Figure 3), presumably reflecting complex in-
stability in the absence of mtDNA-encoded subunits.
Complex I was the most prominently affected and
showed widespread (>75%) reduced expression with
many totally or partially deficient fibers, while other
complexes showed milder abnormalities; the results are
summarized in Table 2.
Comprehensive analysis of paraspinal muscle mtDNA by
massively parallel sequencing detected multiple mtDNA
deletions (Figure 4 and Additional file 1: Figure S1) and a
novel 40.9% heteroplasmic m.12293G >A (MT-TL2) vari-
ant (Additional file 2: Figure S2), which changes a G:C
pairing to an A:C mispairing in the anticodon stem of
tRNA Leu. There was no evidence of mtDNA depletion
(mtDNA copy number was 158% of tissue- and age-
matched control) and no mutations were identified in 14
Figure 2 Paraspinal muscle pathology. Histochemical and ultrastructural analysis of T8 paraspinal muscle demonstrated evidence of a mitochondrial
myopathy. (a) H&E stain (arrows indicate fibers with increase in basophilic staining indicative of mitochondrial hyperplasia), (b) modified trichrome stain
(arrows indicate ragged red fibers), (c) COX (cytochrome c oxidase) stain (asterisks mark COX-negative fibers). Electron microscopy (d-f) shows mitochon-
drial hyperplasia, variation in the mitochondrial shape and size, and mitochondria with crystalline arrays (arrowheads). Of note, the crystalline arrays present
in this case do not have a common “parking lot” appearance. Scale bars: a-c, 50 μm; d, 1.5 μm; e, 1 μm; f, 200 nm.
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mtDNA integrity and the deoxynucleotide salvage pathway
(C10ORF2, DGUOK, MPV17, OPA1, OPA3, POLG,
POLG2, RRM2B, SLC25A4, SUCLG1, SUCLG2, TK2, andTable 1 Mitochondrial respiratory chain enzyme analysis
Complex Electron transport chain activity assay
I NADH : ferricyanide dehydrogenase
I + III NADH : cytochrome C reductase (total)
NADH : cytochrome C reductase (rotenone sensitive)
II Succinate dehydrogenase
II + III Succinate : cytochrome C reductase
IV Sytochrome C oxidase
None Citrate synthase (mitochondrial content marker)
1Control values for quadriceps femoris (control values for paraspinal muscle are notTYMP). Finally, no mtDNA abnormalities were detected
in the blood of either the patient or her son, indicating that
mtDNA abnormalities present in the paraspinal muscle






548 154% 280 +/− 91
34.2 86% 28.2 +/− 4.3
5.3 46% 9.1 +/− 2.5
12.5 122% 8.1 +/−2.44
3.19 51% 4.9 +/− 1.1
45.2 122% 29.2 +/− 9.1
355 100% 280 +/− 95
available).
Figure 3 Mitochondrial respiratory chain immunofluorescence. Immunofluorescence staining (green) for Complex I (30 kD NDUFS3) [(a) and
(g)], Complex II (30 kD FeS protein) (b), Complex III (core 2) (c), Complex IV-I (IV subunit I) (d), Complex IV-IV (IV subunit IV) [(e) and (h)], and
Complex V (OSCP) (f); immunofluorescence staining for porin (red) is a reference control for mitochondrial density and distribution. Arrows,
examples of partially deficient fibers; arrowheads, examples of totally deficient fibers; asterisk, an example of the area with fibers showing
mitochondrial hypodensity. Original magnification: a-f, 100x; g-h, 400x.
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In the current report, we describe a patient with rapidly
progressive adult-onset scoliosis (Figure 1) whose para-
spinal muscle biopsy was diagnostic of a mitochondrial
myopathy. Histochemical examination demonstratedTable 2 Mitochondrial respiratory chain immunofluorescence





IV-IV COX IV3 25%-75%
V OSCP3 <25%
PDH PDH E1α3 >75%
1“Reduced staining” included totally deficient fibers, partially deficient fibers, and fib
as variable focal (<25% of the tissue area), variable regional (25-75% of the tissue a
2For each complex, fibers with strong red (porin) staining but no green staining we
considered partially deficient, while fibers lacking both red and green staining were
as ≥ 10% of muscle fibers in the entire specimen.
3Nuclear DNA-encoded subunit.
4mtDNA-encoded subunit.numerous ragged red and COX-negative fibers, while ul-
trastructural analysis showed mitochondrial hyperplasia
and hypertrophy with abundant abnormal mitochondria
and frequent crystalline arrays (Figure 2). Although ho-
mogenized paraspinal muscle tissue did not showanalysis








ers with hypodensity of mitochondria; the involved area was semi-quantified
rea) and widespread (>75% of the tissue area).
re considered totally deficient, fibers with patchy green and red staining were
considered to show mitochondrial hypodensity. Frequent was defined
Figure 4 (See legend on next page.)
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Figure 4 Multiple mtDNA deletions are detected by next generation sequencing (NGS). (a) NGS coverage profile suggests the presence of
multiple mtDNA deletions, as described previously [12]. Further alignment of mismatched junction sequences identified multiple breakpoints; at
least one possible 5′ deletion breakpoint (b) and two possible 3′ deletion breakpoints [(c) and (d)] were confirmed by Sanger sequencing
(Additional file 1: Figure S1).
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http://www.actaneurocomms.org/content/2/1/137statistically significant biochemical deficits in electron
transport chain activity assays (Table 1), mitochondrial
immunofluorescence analysis revealed many totally and
partially deficient fibers for complexes I, III, IV-I, and
IV-IV (Table 2 and Figure 3). No deleterious mutations
were found in fourteen nuclear genes known to influ-
ence mitochondrial DNA fidelity, but massively parallel
sequencing of mtDNA identified multiple deletions
(Figure 4 and Additional file 1: Figure S1) and a novel
heteroplasmic (40.9%) variant in the MT-TL2 gene
(Additional file 2: Figure S2), which changes guanine
12293 to adenine (m.12293G > A) (Figure 5).
What is the clinical significance of this novel mtDNA
variant, which is not listed as a polymorphism in the Mito-
map and mtDB mtDNA databases and was not detected in
~ 5000 individuals whose mtDNA was sequenced by the
Baylor Medical Genetics Laboratories? The m.12293G >A
mutation changes a G:C pairing to an A:C mispairing in
the anticodon stem of MT-TL2 (tRNA LeuCUN); this pos-
ition is conserved in all organisms examined by Weber et
al. [15] and is adjacent to a similar mutation (m.12294G >
A) that causes chronic progressive external ophthalmople-
gia (CPEO), a classic mitochondrial disorder [16]. Several
other point mutations in the MT-TL2 gene have beenFigure 5 Schematic diagram of MT-TL2. Novel G12293A mutation
is localized to the anticodon stem of the MT-TL2 (red arrow). Multiple
point mutations in this tRNA exist, and have been linked to diseases
including CPEO (residues in blue), MELAS (residue in green), and other
mitochondrial myopathies (residues in yellow).implicated in mitochondrial diseases, including CPEO,
MELAS (mitochondrial myopathy, encephalopathy, lactic
acidosis, and stroke syndrome), and other mitochondrial
myopathies including isolated dilated cardiomyopathy [17–
21,15,22,16]. The absence of m.12293G >A (MT-TL2) vari-
ant in the patient’s blood suggests that this mtDNA variant
is a novel point mutation that can lead to an isolated skeletal
muscle (in this case paraspinal) myopathy. However, analysis
of the patient’s paraspinal muscle mtDNA also showed
multiple mtDNA deletions (Figure 4 and Additional file 1:
Figure S1) that likely contributed to the mitochondrial my-
opathy phenotype; thus, studies of cybrids (immortalized
cells whose mitochondria have been replaced by mitochon-
dria with the point mutation of interest [23]) will be re-
quired to definitively demonstrate the pathogenicity of the
newly identified MT-TL2 mutation.
Interestingly, the patient first developed scoliosis in
the late adolescence, but her symptoms remained stable
until age 65, when she experienced rapid progression.
The family history of scoliosis (the patient’s mother and
son also developed scoliosis in the mid-late adolescence)
raised the possibility that a maternally-inherited mtDNA
mutation was the underlying cause of their spine de-
formity, as was recently demonstrated for a family with
a late-onset axial myopathy due to a mutation in the
mitochondrial tRNA Phe gene [8]. However, no mtDNA
abnormalities were identified in the patient’s son’s blood
(to date, he has not undergone a muscle biopsy). The pa-
tient’s mother is deceased and her blood was not avail-
able for genetic testing; interestingly, however, her
scoliosis remained stable throughout the whole adult life
(> seven decades). Thus, it is likely that the patient’s ini-
tial scoliosis, which was relatively mild and remained
stable for more than four decades, represents a separate
familial disorder that still has an unexplained etiology; in
contrast, the rapidly-progressive scoliosis the patient devel-
oped at the age of 65 is a consequence of the primary axial
mitochondrial myopathy caused by the accumulation of
somatic mtDNA abnormalities, including multiple mtDNA
deletions and m.12293G >A mtDNA mutation. An alterna-
tive (but less likely) possibility is that m.12293G >A (MT-
TL2) mutation is present in the patient’s blood and other
tissues, but is below the current detection limit of the mas-
sively parallel sequencing (1% of heteroplasmy); in that sce-
nario, the familial non-progressive scoliosis developed by all
three family members would be due to m.12293G >A
(MT-TL2) mutation, while the rapid symptom progression
experienced only by our patient would be attributed to
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tient’s son undergoes a paraspinal muscle biopsy in the fu-
ture, it may be possible to definitively differentiate between
these two scenarios.
Despite obvious morphologic and genetic abnormalities
present in the patient’s muscle biopsy, no significant defi-
ciencies of electron transport chain enzymes were detected
using standard biochemical assays (Table 1). In contrast, im-
munofluorescence assays for expression of five respiratory
chain complexes showed widespread abnormalities (Figure 3
and Table 2). The discrepancy between the two methods
could be due to a difference in sensitivity between imaging
assays (which can distinguish affected from non-affected
cells) and biochemical assays (which are performed on tissue
homogenates). An additional methodological issue is the
lack of proper enzyme activity control values for infre-
quently biopsied tissues (such as the paraspinal muscle): as
in our case, a non-significant decrease in the complex I and
IV activities was reported in a case of a familial axial myop-
athy associated with tRNA Phe mutation [8]. Finally, a prob-
lem with inter-laboratory reproducibility of mitochondrial
respiratory chain biochemical assays has been reported
[24,25]. Thus, performing immunofluorescence in parallel
with biochemical testing may increase the detection sensitiv-
ity for respiratory chain abnormalities, particularly when
changes in the mitochondrial enzyme activity approach but
do not meet the threshold for statistical significance.
In summary, this case illustrates that mitochondrial
myopathy can underlie rapidly-progressive adult-onset
scoliosis in the absence of significant chronic myopathic
changes and that mitochondrial disorders should be
considered in the differential diagnosis of the primary
axial myopathy.
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variant was confirmed by Sanger sequencing.
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